
AGC Biologics Achieves FDA Approval for Biosimilar at Copenhagen Facility
AGC Biologics has received FDA commercial approval for a biosimilar at its Copenhagen facility, marking a significant milestone in the company's growth and capabilities in the expanding biosimilar market.
Read full story




















